Copyright
©The Author(s) 2022.
World J Clin Cases. Aug 6, 2022; 10(22): 7859-7871
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7859
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7859
Table 4 League table with OR estimates of each pair of interventions accompanied by 95%CI according to the prevention of mild PEP (significant difference when OR < 1 and CI < 1)
Indomethacin+GTN | Diclofenac 100 mg | Indomethacin | tra-GTN | Naproxen | Diclofenac 50 mg | Placebo |
0.59 (0.19, 1.86) | ||||||
0.46 (0.19, 1.12) | 0.77 (0.35, 1.72) | |||||
0.38 (0.12, 1.20) | 0.65 (0.24, 1.75) | 0.84 (0.38, 1.85) | ||||
0.38 (0.11, 1.35) | 0.64 (0.22, 1.87) | 0.83 (0.32, 2.14) | 0.99 (0.31, 3.14) | |||
0.32 (0.08, 1.39) | 0.54 (0.14, 2.11) | 0.70 (0.21, 2.37) | 0.84 (0.22, 3.19) | 0.85 (0.19, 3.71) | ||
0.27 (0.11, 0.67) | 0.46 (0.23, 0.94) | 0.59 (0.40, 0.88) | 0.71 (0.36, 1.41) | 0.72 (0.29, 1.78) | 0.84 (0.27, 2.66) |
- Citation: Shi QQ, Huang GX, Li W, Yang JR, Ning XY. Rectal nonsteroidal anti-inflammatory drugs, glyceryl trinitrate, or combinations for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: A network meta-analysis. World J Clin Cases 2022; 10(22): 7859-7871
- URL: https://www.wjgnet.com/2307-8960/full/v10/i22/7859.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i22.7859